ArticleEndocrinology, diabetes & metabolism2026
Associations between Serum Zinc Levels and the Presence of Distal Symmetric Polyneuropathy in Patients with Type 2 Diabetes Mellitus.
Article in Endocrinology, diabetes & metabolism, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
3 authors.
Funding
Abstract
introductionDistal Symmetric Polyneuropathy Is the Most Common Form of Diabetic Neuropathy and a Major Source of Morbidity in Type 2 Diabetes. Oxidative Stress Plays a Key Role in Its Pathogenesis, and Zinc-An Essential Trace Element Involved in Antioxidant Defence-Has Been Proposed as a Protective Factor. However, Clinical Evidence on the Association Between Serum Zinc Levels and Diabetic Neuropathy Remains Limited and Inconsistent. This Study Examined the Relationship Between Serum Zinc Levels and the Presence of Distal Symmetric Diabetic Polyneuropathy in Type 2 Diabetes.
methodsThis Nested Case-Control Study Was Conducted Between December 2023 and March 2025 at the Internal Medicine Clinic of Shahid Beheshti Hospital in Hamadan, Iran. Ninety Patients With Type 2 Diabetes Were Enrolled, Including 45 With Distal Symmetric Polyneuropathy and 45 Without Neuropathy, Diagnosed According to American Diabetes Association Criteria. Serum Zinc Levels Were Measured Photometrically. Group Comparisons Used Independent t-Tests and Chi-Square Tests. Multivariable Logistic Regression Analysis Was Used to Examine the Association Between Serum Zinc Levels and DSPN While Adjusting for Potential Confounders.
resultsPatients With Distal Symmetric Polyneuropathy Had Significantly Lower Serum Zinc Levels Than Those Without (70.6 ± 12 μg/dL vs. 82.2 ± 16.9 μg/dL, p < 0.001). In Multivariable Logistic Regression, Zinc Levels Remained Independently Associated With the Presence of Neuropathy; Each One μg/dL Increase Was Associated With a 5.4% Reduction in Odds of Neuropathy.
conclusionsLower serum zinc levels were independently associated with the presence of distal symmetric polyneuropathy in type 2 diabetes. This finding suggests that zinc deficiency may contribute to the development of diabetic neuropathy.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.